Skip to content
Drix10 Blog

OpenMed 3.0 patient matcher integration

, 7 items in AI in Healthcare and Science, 4 min read

In this digest (7 items)

OpenMed 3.0 accepts any patient matcher for scoring candidates but does not perform linking. The resolver returns ambiguous results, sets review_required=True, and provides no canonical key until a person decides. Exact links that have already been reviewed pass through directly.

Key points

  • Patient matcher can score candidates in OpenMed 3.0 but cannot link them.

  • Resolver returns ambiguous, review_required=True, and no canonical key until manual decision; reviewed exact links go straight through.

Sources

Sex-linked immune aging observed in mice and humans

Male mice lost naive CD8 T cells earlier than females, weakening melanoma recognition. Human data supported key aspects of this sex-linked pattern of immune aging.

Key points

  • Male mice lost naive CD8 T cells earlier than females, weakening melanoma recognition.

  • Human data supported key aspects of this sex-linked pattern of immune aging.

Sources

Stronger fevers after vaccination linked to gut microbes

Stronger fevers after vaccination were linked to gut microbial differences already present before the shot. The differences included more active genes for bacterial swimming.

Key points

  • Stronger fevers after vaccination linked to gut microbial differences present before the shot

  • More active genes for bacterial swimming were among the differences

Sources

OpenMed 3.0 probabilistic match does not auto‑merge records

OpenMed 3.0 uses a probabilistic match that never merges two records automatically. A candidate with 99% confidence or two candidates with 94% and 91% confidence are sent to a human reviewer. A wrong merge could place one patient’s allergy list in another patient’s chart.

Key points

  • Probabilistic match never merges records on its own in OpenMed 3.0.

  • Matches at 99% or at 94% and 91% are routed to a human reviewer.

Sources

Berlin labs on October 22 – BioNeMo and Isaac for Healthcare

BioNeMo will be demonstrated at 9:00 for drug discovery. Isaac for Healthcare will be shown at 13:00 for medical robotics. Both sessions are part of hands‑on labs in Berlin.

Key points

  • 9:00 – Drug discovery with BioNeMo

  • 13: 00 – Medical robotics with Isaac for Healthcare

Sources

AnagenXYZ early human pilot of slow-release minoxidil; PeptAI protein design entry

AnagenXYZ (HairDAO) announced an early human pilot of slow-release minoxidil. PeptAI posted a protein design competition entry. Both are part of September’s Bio ecosystem research updates.

Key points

  • Early human pilot of slow-release minoxidil by AnagenXYZ (HairDAO)

  • Protein design competition entry by PeptAI

Sources

Olive oil preload lowers early glucose rise in mice

Olive oil given 15 minutes before oral glucose reduces the early increase in blood sugar in mice. The effect remains in mice with severe insulin deficiency. The study also links the effect to slower gastric emptying and hormone changes.

Key points

  • Olive oil before glucose blunted the early blood sugar rise versus oil given after glucose.

  • The benefit was retained in mice with severe insulin deficiency.

Sources